"Although small, early-phase studies hint that stem cells could become a promising treatment pathway for these conditions, there are no large, rigorous trials showing that they are safe and effective, says Andrés Gómez de León, a haematologist at the Autonomous University of Nuevo León in Monterrey, Mexico."
"R3 Stem Cell's founder David Greene says that there are hundreds of peer-reviewed studies on the benefits of stem cells for many conditions, but adds that 'there will always be arguments against new technology such as stem-cell therapy, especially from biased competitors and academics who dislike commercial endeavours'."
"In Mexico, the company's treatments cost anything from US$3,750 to $44,500, according to its website - roughly one-third as much as equivalent treatments in the United States (where available). Although these therapies are not approved by the FDA, there is great demand for them in Mexico."
R3 Stem Cell operates clinics in Tijuana, Cancun, and Puerto Vallarta, offering stem cell therapies for conditions including diabetes, lung disorders, autism, and cerebral palsy. While small early-phase studies suggest potential benefits, no large rigorous trials demonstrate safety and effectiveness. The company claims hundreds of peer-reviewed studies support stem cell benefits and maintains FDA-level safety standards. Treatments cost $3,750 to $44,500 in Mexico, approximately one-third of US prices. Demand has doubled over two years. These therapies lack FDA approval and official approval from Mexico's COFEPRIS, though Mexico lacks specific regulatory laws for advanced cell-based therapies.
Read at Nature
Unable to calculate read time
Collection
[
|
...
]